The Relative Clinical and Economic Value of Ipilimumab in the Treatment of Metastatic Melanoma Versus Other Anti-Cancer Agents for Metastatic Diseases from a Brazilian Private Health Care System Perspective
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.250
https://www.valueinhealthjournal.com/article/S1098-3015(15)02326-8/fulltext
Title :
The Relative Clinical and Economic Value of Ipilimumab in the Treatment of Metastatic Melanoma Versus Other Anti-Cancer Agents for Metastatic Diseases from a Brazilian Private Health Care System Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02326-8&doi=10.1016/j.jval.2015.09.250
First page :
A819
Section Title :
Research Podium Presentations - Session 1
Open access? :
No
Section Order :
2471